Axxelent Pharma gets compliance certificate for facility in Sri City

Hyderabad: Axxelent Pharma Science Pvt Ltd, a contract development and manufacturing company announced receiving the Health Canada Current Good Manufacturing Practices (cGMPs) compliance certification for its non-sterile facility situated in Sri City SEZ, Andhra Pradesh. Health Canada had inspected the facility in September 2024.

Jitesh Devendra, Co-Founder and Chairman, Axxelent Pharma Science Pvt Ltd, said: “We are pleased to announce the outcome of our first Health Canada cGMP inspection for our non-sterile facility which covers Oral Solids, Oral Liquids and Semi-Solids. This follows completion of our first US FDA inspection in August 2024 for our Oral Solid facility. Further inspections for our other dosage forms are expected in the upcoming 12 months from other Regulatory agencies.” He further said that “the next step is to trigger our Sterile facility with the qualification expected to complete by Q3 FY25. The successful completion of the regulatory inspections reflects our commitment to maintaining high standards and ensuring compliance with all regulations.”